Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/73269
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThompson, S.-
dc.date.issued2012-
dc.identifier.citationWorld Journal of Surgery, 2012; 36(1):118-119-
dc.identifier.issn0364-2313-
dc.identifier.issn1432-2323-
dc.identifier.urihttp://hdl.handle.net/2440/73269-
dc.description.statementofresponsibilitySarah K. Thompson-
dc.language.isoen-
dc.publisherSpringer-
dc.rights© Société Internationale de Chirurgie 2011-
dc.source.urihttp://dx.doi.org/10.1007/s00268-011-1324-z-
dc.subjectHumans-
dc.subjectStomach Neoplasms-
dc.subjectVascular Endothelial Growth Factor A-
dc.subjectFemale-
dc.subjectMale-
dc.subjectBiomarkers, Tumor-
dc.titleTargeting angiogenesis in gastroesophageal cancer: Industry-sponsored trials are not the answer-
dc.typeJournal article-
dc.identifier.doi10.1007/s00268-011-1324-z-
pubs.publication-statusPublished-
Appears in Collections:Aurora harvest
Surgery publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.